NSC 601980 analog is primarily utilized in cancer research due to its potential as an antitumor agent. It is studied for its ability to inhibit specific cellular pathways that promote cancer cell growth and survival. Researchers explore its efficacy in targeting various types of cancers, particularly those resistant to conventional therapies. The compound is often used in preclinical studies to evaluate its impact on tumor regression and its potential to enhance the effectiveness of existing chemotherapy drugs. Additionally, it is investigated for its role in inducing apoptosis in cancer cells, making it a promising candidate for developing novel anticancer treatments. Its application extends to understanding molecular mechanisms involved in cancer progression and identifying new therapeutic targets.